ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Chemo Can Harm Liver, Affect Surgical Outcomes

May 26, 2006

Farber Grant Probe Misses Real Story

July 8, 1977

Lifestyle Changes Common After Cancer Diagnosis

August 26, 2005

In Brief: All 77 New NCI Positions Go to Carcinogenesis Programs; “Not Wisest Way To Use Them” – Newell

February 4, 1977

In Brief: New Clinical Oncology RFP Ready Soon; CCIRC, Joftes Agree On Funding Method For Symposia

March 9, 1979

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

January 10, 1997